Showing results (11-20 of 419) with videos related to

Sort By:
Pageof 42
Lens and Eye Toxicity Research|January 1, 1990
Pravastatin--ocular side effects after a two year follow-up?W Behrens-Baumann, J Thiery, H G Fieseler, et al.
Helvetica Chirurgica Acta|December 1, 1994
[Can hyperlipidemia after heart transplantation be optimally and safely treated?]K Wenke, J Thiery, N Arndtz, et al.
Acta Oto-Laryngologica|February 25, 2000
Clinical utility of LDL-apheresis in the treatment of sudden hearing loss: a prospective, randomized studyM Suckfüll, J Thiery, K Schorn, et al.
Klinische Wochenschrift|August 17, 1990
Effects of long-term treatment with simvastatin on plasma lipids and lipoproteins in patients with primary hypercholesterolemiaJ Thiery, C Creutzfeldt, W Creutzfeldt, et al.
The International Journal of Artificial Organs|February 1, 1993
Reverse flux filtration: a new mode of therapy improving the efficacy of heparin-induced extracorporeal LDL precipitation in hyperlipidemic hemodialysis patientsT Bosch, W Samtleben, J Thiery, et al.
Lens and Eye Toxicity Research|January 1, 1989
Ocular side effects of the lipid-lowering drug simvastatin? A one year follow-upW Behrens-Baumann, A Morawietz, J Thiery, et al.
European Journal of Clinical Investigation|April 1, 1996
Hyperlipoprotein(a)aemia in nephrotic syndromeJ Thiery, B Ivandic, G Bahlmann, et al.
Zeitschrift Fur Kardiologie|February 1, 1995
[Therapy of hypercholesterolemia after heart transplantation with the HMG-CoA reductase inhibitor simvastatin in long-term follow-up]K Wenke, J Thiery, B Meiser, et al.
Atherosclerosis|February 10, 1997
Expression of vascular cell adhesion molecule-1 (VCAM-1) in the aortae of hypercholesterolemic rabbits with high (HAR) and low (LAR) atherosclerotic responseD Teupser, J Thiery, U Haas, et al.
Arzneimittel-Forschung|August 1, 1992
3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitor simvastatin and the human lens. Clinical results of a 3-year follow-upW Behrens-Baumann, J Thiery, E Wieland, et al.
Pageof 42